Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of intravesically administered Bacillus Calmette-Guérin (BCG) plus interferon(IFN)-alpha(α) compared with BCG alone for treating non-muscle-invasive bladder cancer (NMIBC).
Original language | English |
---|---|
Article number | CD012112 |
Journal | Cochrane Database of Systematic Reviews |
Volume | 2016 |
Issue number | 3 |
DOIs | |
Publication status | Published or Issued - 5 Mar 2016 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology (medical)